Sex is a strong prognostic factor in stage IV non-small-cell lung cancer patients and should be considered in survival rate estimation.

doi:10.1016/j.canep.2020.101737

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Sex is a strong prognostic factor in stage IV non-small-cell lung cancer patients and should be considered in survival rate estimation.

Cancer epidemiology - 1 Aug 2020

Barquín Miguel, Calvo Virginia, García-García Francisco, Nuñez Beatriz, Sánchez-Herrero Estela, Serna-Blasco Roberto, Auglytė Milda, Carcereny Enric, Rodriguez-Abreu Delvys, López Castro Rafael, Guirado María, Camps Carlos, Bosch-Barrera Joaquín, Massuti Bartomeu, Ortega Ana Laura, Del Barco Edel, Gonzalez-Larriba José Luis, Aguiar David, García-Campelo Rosario, Dómine Manuel, Agraso Sara, Sala Mª Angeles, Oramas Juana, Bernabé Reyes, Blanco Remei, Parejo Consuelo, Cruz Alberto, Menasalvas Ernestina, Royuela Ana, Romero Atocha, Provencio Mariano

Abstract excerpt

BACKGROUND: Biological differences between the sexes have a major impact on disease and treatment outcome. In this paper, we evaluate the prognostic value of sex in stage IV non-small-cell lung cancer (NSCLC) in the context of routine clinical data, and compare this information with other external datasets. METHODS: Clinical data from stage IV NSCLC patients from Hospital Puerta de Hierro (HPH) were retrieved...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Lung Neoplasms

Share to Meta-Analysis as Topic

Share to Neoplasm Staging

Share to Protein Kinase Inhibitors

Share to Sex Factors

Share to Survival Rate

Source

Open in PubMed

Identifiers

PMID: 32450544
DOI: 10.1016/j.canep.2020.101737

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Sex is a strong prognostic factor in stage IV non-small-cell lung cancer patients and should be considered in survival rate estimation.PMID 32450544Read ↗

Sex differences in small cell lung cancer: Epidemiology and geneticsSemantic proximity Read ↗

Gender-associated differences in lung cancer: clinical characteristics and treatment outcomes in women.Semantic proximity Read ↗

Sex-based differences in lung cancer susceptibility and molecular genetics in the 2020sSemantic proximity Read ↗

[Is lung cancer in women different?].Semantic proximity Read ↗

Sex-differential responses to immune checkpoint inhibitors across the disease continuum unified by tumor mutational burden.Semantic proximity Read ↗

A population-based study describing characteristics, survival and the effect of TKI treatment on patients with EGFR mutated stage IV NSCLC in the Netherlands.Semantic proximity Read ↗

Sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in males, smokers, and non-adenocarcinoma lung cancer in patients with EGFR mutations.Semantic proximity Read ↗

Comparison of Clinical and Genetic Characteristics Between Younger and Older Lung Cancer Patients.Semantic proximity Read ↗

Sex-based molecular and prognostic disparities in pan-cancer: an analysis across the global cohorts.Semantic proximity Read ↗

Sex-biased molecular differences in lung adenocarcinoma are ethnic and smoking specific.Semantic proximity Read ↗

Comprehensive Characterization of Molecular Differences in Cancer between Male and Female Patients.Semantic proximity Read ↗

An overview of mortality & predictors of small-cell and non-small cell lung cancer among Saudi patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.